See maximum funding amount and funding details below
Eligibility:
Clinician Educators
Instructors
Medical Center Line Faculty
Postdocs
Students
Applications not yet open
Application submissions will open on July 27, 2026
Approximate Offer Date:
January 1st, 2027
Program Overview
The Stanford SPARK program supports the discovery and development of novel therapeutics and diagnostics that address unmet medical needs. SPARK offers funding, education regarding the multi-disciplinary product development process, and project-specific mentorship to enable faculty and trainees to advance promising research discoveries to the clinic and/or commercial sector. Much of the mentorship and education is provided by volunteer advisors from the local biotechnology ecosystem. Education and mentorship are available across the entire spectrum of drug and diagnostic development including the following areas: intellectual property and patent law; assay development; optimization of therapeutic chemical structures; preclinical pharmacology and proof of concept studies; preclinical safety and pharmacokinetics; regulatory science and regulatory agency expectations; clinical study design and conduct; and commercialization/start-up company funding and incorporation. Approximately 55% of projects that complete SPARK advance to commercial partnerships and/or clinical trials.
Proposals will be reviewed by a selection committee comprised of Stanford faculty and industry experts. Based on the compiled rankings, finalists will be invited to present an oral pitch to the review panel in early December, 2026. The number of proposals selected for awards will be dependent on available funding and awardees will be notified before the end of December, 2026. Initial funding is generally for $50,000 with the possibility of up to 100,000 over two years.
Proposals will be evaluated based on the following three criteria:
meeting clear unmet medical need
novelty of approach
feasibility of the path to clinic
Areas of interest:
Any clinical indication with an unmet need will be considered. Thanks to generous support from MCHRI, targeted funds are available for projects related to maternal and child health. In addition, SPARK encourages applications related to global health or addressing needs of diverse populations.
Program priorities
Translational research
Drug development
Diagnostics
Education
Eligibility:
Stanford faculty with UTL, MCL, NTLR and CE faculty* appointments
Instructors and Clinical Instructors are eligible only with faculty PI waiver
Graduate students and postdoctoral scholars (clinical and non-clinical) are required to include a PI eligible faculty member as co-PI on the application.
Requirements:
Selected awardees are expected to attend weekly Wednesday evening SPARK meetings and present project updates each quarter. In addition, awardees are required to meet with their project manager on a monthly basis.
The Stanford SPARK program must be cited in all publications and presentations that describe work supported by SPARK. In addition, we require acknowledgement of SPARK funding in relevant disclosures to Stanford OTL.